Jubilant Pharmova: Strong Showing in June Quarter
Moneylife Digital Team 27 July 2021
Jubilant Pharmova Ltd (JPL) delivered a growth of 3% q-o-q (quarter-on-quarter) in revenue in Q1FY21-22 due to gradual recovery in all segments. Operating profit remained flat q-o-q at Rs375 crore with operating margins at 23%, as against 24% in Q4FY20-21. Net profit grew marginally by 1% q-o-q to Rs170 crore with net profit margins dipping to 10% in Q1FY21-22.
JPL is...
Premium Content
This is a premium article. Your annual or monthly subscription will not give you access if it is outside your subscription period. You can buy it individually
Pay Per Article Gift An Article
Access will cover your subscription period. Archives not included. Articles outside the subscription period can be bought individually.
Yearly Digital Access Monthly Digital Access
Already a subscriber ? Log in
Free Helpline
Legal Credit